Cargando…

Inhibition of Vascular Inflammation by Apolipoprotein A-IV

BACKGROUND: Apolipoprotein (apo) A-IV, the third most abundant apolipoprotein in human high density lipoproteins (HDLs), inhibits intestinal and systemic inflammation. This study asks if apoA-IV also inhibits acute vascular inflammation. METHODS: Inflammation was induced in New Zealand White rabbits...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shearston, Kate, Tan, Joanne T. M., Cochran, Blake J., Rye, Kerry-Anne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279673/ https://www.ncbi.nlm.nih.gov/pubmed/35845068 http://dx.doi.org/10.3389/fcvm.2022.901408

Ejemplares similares

The apolipoprotein A-I mimetic peptide, ETC-642, reduces chronic vascular inflammation in the rabbit
por: Di Bartolo, Belinda A, et al.
Publicado: (2011)

Long Non-Coding RNAs in Vascular Inflammation
por: Haemmig, Stefan, et al.
Publicado: (2018)

Defective Protein Catabolism in Atherosclerotic Vascular Inflammation
por: Miyazaki, Takuro, et al.
Publicado: (2017)

Endothelial-to-Mesenchymal Transition, Vascular Inflammation, and Atherosclerosis
por: Chen, Pei-Yu, et al.
Publicado: (2020)

Message in a Microbottle: Modulation of Vascular Inflammation and Atherosclerosis by Extracellular Vesicles
por: van der Vorst, Emiel P. C., et al.
Publicado: (2018)

Genetic Regulatory Networks of Apolipoproteins and Associated Medical Risks
por: Basavaraju, Preethi, et al.
Publicado: (2022)

The Role of Iron in Atherosclerosis in Apolipoprotein E Deficient Mice
por: Ma, Juan, et al.
Publicado: (2022)

Peptidylarginine deiminase 4 deficiency in bone marrow cells prevents plaque progression without decreasing atherogenic inflammation in apolipoprotein E-knockout mice
por: Paunel-Görgülü, Adnana, et al.
Publicado: (2022)

Vascular Inflammation in Mouse Models of Systemic Lupus Erythematosus
por: Ryan, Holly, et al.
Publicado: (2022)

Patrolling Mechanics of Non-Classical Monocytes in Vascular Inflammation
por: Buscher, Konrad, et al.
Publicado: (2017)

Short-Term Supplementation With Fermented Red Clover Extract Reduces Vascular Inflammation in Early Post-menopausal Women
por: Wickham, Kate A., et al.
Publicado: (2022)

Editorial: Cardiovascular diseases in autoimmune diseases: Dyslipidemia and vascular inflammation
por: Solow, E. Blair, et al.
Publicado: (2022)

Thrombosis and Vascular Inflammation in Diabetes: Mechanisms and Potential Therapeutic Targets
por: Pechlivani, Nikoletta, et al.
Publicado: (2018)

Krüppel-Like Factors in Vascular Inflammation: Mechanistic Insights and Therapeutic Potential
por: Sweet, David R., et al.
Publicado: (2018)

Editorial: New Trends in Vascular Inflammation Research: From Biology to Therapy
por: Aikawa, Masanori, et al.
Publicado: (2019)

Vascular Inflammation as a Therapeutic Target in COVID-19 “Long Haulers”: HIITing the Spot?
por: Christensen, Regitse Højgaard, et al.
Publicado: (2021)

Apolipoprotein A-I enhances insulin-dependent and insulin-independent glucose uptake by skeletal muscle
por: Tang, Shudi, et al.
Publicado: (2019)

Single-cell transcriptomes and T cell receptors of vaccine-expanded apolipoprotein B-specific T cells
por: Nettersheim, Felix Sebastian, et al.
Publicado: (2023)

The Role of Tumor Necrosis Factor Associated Factors (TRAFs) in Vascular Inflammation and Atherosclerosis
por: Gissler, Mark Colin, et al.
Publicado: (2022)

Reduction of Vascular Inflammation, LDL-C, or Both for the Protection from Cardiovascular Events?
por: Reklou, Andromachi, et al.
Publicado: (2018)

Role of inflammation and immunity in vascular calcification: a bibliometric and visual analysis, 2000–2022
por: Wang, Chen, et al.
Publicado: (2023)

No Significant Role for Smooth Muscle Cell Mineralocorticoid Receptors in Atherosclerosis in the Apolipoprotein-E Knockout Mouse Model
por: Moss, M. Elizabeth, et al.
Publicado: (2018)

Next-Generation and Single-Cell Sequencing Approaches to Study Atherosclerosis and Vascular Inflammation Pathophysiology: A Systematic Review
por: McQueen, Liam W., et al.
Publicado: (2022)

Polymorphisms of the apolipoprotein E gene affect response to atorvastatin therapy in acute ischemic stroke
por: Bi, QianQian, et al.
Publicado: (2022)

Prevalence and Impact of Apolipoprotein E7 on LDL Cholesterol Among Patients With Familial Hypercholesterolemia
por: Tada, Hayato, et al.
Publicado: (2021)

Paradoxical Association Between Baseline Apolipoprotein B and Prognosis in Coronary Artery Disease: A 36,460 Chinese Cohort Study
por: Li, Huanqiang, et al.
Publicado: (2022)

The intersection of obesity and (long) COVID-19: Hypoxia, thrombotic inflammation, and vascular endothelial injury
por: Xiang, Mengqi, et al.
Publicado: (2023)

Oral microbiome mediated inflammation, a potential inductor of vascular diseases: a comprehensive review
por: Gualtero, Diego F., et al.
Publicado: (2023)

Dual pathway inhibition as compared to acetylsalicylic acid monotherapy in relation to endothelial function in peripheral artery disease, a phase IV clinical trial
por: Willems, Loes H., et al.
Publicado: (2022)

Systemic and local vascular inflammation and arterial reactive oxygen species generation in patients with advanced cardiovascular diseases
por: Sulicka-Grodzicka, Joanna, et al.
Publicado: (2023)

Case Report: Hypertriglyceridemia and Premature Atherosclerosis in a Patient With Apolipoprotein E Gene ε2ε1 Genotype
por: Limonova, Alena S., et al.
Publicado: (2021)

A nonlinear relationship between systemic inflammation response index and short-term mortality in patients with acute myocardial infarction: a retrospective study from MIMIC-IV
por: Wang, Yufei, et al.
Publicado: (2023)

Autoimmune Regulator (AIRE) Deficiency Does Not Affect Atherosclerosis and CD4 T Cell Immune Tolerance to Apolipoprotein B
por: Nettersheim, Felix Sebastian, et al.
Publicado: (2022)

Low Molecular Weight Apolipoprotein(a) Phenotype Rather Than Lipoprotein(a) Is Associated With Coronary Atherosclerosis and Myocardial Infarction
por: Afanasieva, Olga I., et al.
Publicado: (2022)

Slow flow induces endothelial dysfunction by regulating thioredoxin-interacting protein-mediated oxidative metabolism and vascular inflammation
por: Wang, Yongshun, et al.
Publicado: (2022)

S100/RAGE-Mediated Inflammation and Modified Cholesterol Lipoproteins as Mediators of Osteoblastic Differentiation of Vascular Smooth Muscle Cells
por: Chellan, Bijoy, et al.
Publicado: (2018)

High Density Lipoprotein and Its Precursor Protein Apolipoprotein A1 as Potential Therapeutics to Prevent Anthracycline Associated Cardiotoxicity
por: Kluck, George E. G., et al.
Publicado: (2020)

Circulating Autoantibodies Recognizing Immunodominant Epitopes From Human Apolipoprotein B Associate With Cardiometabolic Risk Factors, but Not With Atherosclerotic Disease
por: Marchini, Timoteo, et al.
Publicado: (2022)

Effect of fenofibrate on plasma apolipoprotein C-III levels: a systematic review and meta-analysis of randomised placebo-controlled trials
por: Sahebkar, Amirhossein, et al.
Publicado: (2018)

AMPK: Potential Therapeutic Target for Vascular Calcification
por: Lu, Yi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l6ip2pavsl3qkv2kp41ja2550p